MedPath

A clinical trial to study the effect of a polyherbomineral drug, Eladi Churna in patients with diabetic kidney disease.

Phase 1
Conditions
Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications
Registration Number
CTRI/2023/06/054530
Lead Sponsor
Dr Jupitora Dutta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients coming under diagnostic criteria of DKD

2.Patients with and without Dialysis

3.Patients between 18 years to 70 years of age irrespective of sex

Exclusion Criteria

1.Patients less than 18 years and more than 70 years

2.Patients suffering from CAD

3.CLD

4.MALIGNANCY

5.TB

6.ASCITES

7.STD

8.Pregnant,Expecting and lactating mothers

9.Other complications of Diabetes Mellitus

10.Patient with recurrent UTI

11.marked HTN as it fallaciously rise microalbuminuria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath